It is known that high levels of FKBP51 lead to reduced Akt phosphorylation/activity and increased chemosensitivity, whereas low levels of FKBP51 lead to increased Akt phosphorylation/activity and chemoresistance of cancer cells of the prostate, breast, and pancreas [24, 25]. Here, AKT1 is linked to cancer.